Healthcare & Medical Investment Corporation
Notice Regarding Fund Borrowing
This investment corporation will raise funds via a social loan framework. Total borrowings amount to 8.0 billion yen across two items (50 hundred million yen and 30 hundred million yen), long-term, unsecured, and unguaranteed, with repayments planned around 2030. Funds will be allocated to acquire part of the asset trust beneficiary rights and cover related expenses. A third-party evaluation under JC R’s Social Finance Framework (F) has been obtained.
Key Figures
- Borrowings①: 50 hundred million yen
- Borrowings②: 30 hundred million yen
- Borrowings execution date ①: September 1, 2026
- Borrowings execution date ②: September 30, 2026
- Increase in long-term borrowings: +10,500 million yen
AI要約
Overview of Financing
This investment corporation will execute borrowings through a social loan under the Social Finance Framework. Borrowing ① is 50 billion yen, Borrowing ② is 30 billion yen, both long-term, unsecured, and unguaranteed, with repayments planned around around 2030. The funds will be allocated for acquiring part of the target asset’s trust beneficiary rights and for related expenses. As an external evaluation, JC R’s Social Finance Framework evaluation (F) has been obtained.
Financial impact, risks and considerations
Total borrowings will increase after the borrowing, with changes in the composition of short-term and long-term borrowings. Repayment terms and interest rates are variable, based on Zengin Association’s TIBOR, with the first interest payment date set for the end of September 2026. There are no changes to the contents of the risk disclosures (e.g., repayment risk) described in the submitted securities report.
Healthcare & Medical Investment Corporation
Company overview · Stock price · Financial data · All IR
